Literature DB >> 8875555

Importance of the form of topical vitamin E for prevention of photocarcinogenesis.

H L Gensler1, M Aickin, Y M Peng, M Xu.   

Abstract

With increasing solar ultraviolet (UV)-B radiation reaching the Earth's surface and the incidence of skin cancer rising steadily, there is an ever-increasing need to determine agents that modulate photocarcinogenesis and to understand the mechanisms underlying this modulation. Our laboratory has demonstrated that topical application of the dl-alpha-tocopherol form of vitamin E to mice prevents skin cancer and the immunosuppression induced by UVB irradiation. However, dl-alpha-tocopherol has limited stability at room temperature. The current study was designed to ask whether the thermostable esters of vitamin E, alpha-tocopheryl acetate, or alpha-tocopheryl succinate prevent skin cancer and immunosuppression induced in mice by UV radiation. In the alpha-tocopheryl acetate study, skin cancers developed in 70% of UVB-irradiated control mice and in 90%, 73%, and 90% of mice receiving topical applications of 12.5, 25, and 50 mg of dl-alpha-tocopheryl acetate, respectively. In the alpha-tocopheryl succinate study, skin cancer developed in 59.3% of control UVB-irradiated mice and in 82%, 100%, and 81.5% of mice treated with 2.5, 12.5, and 25 mg d-alpha-tocopheryl succinate, respectively. Thus neither alpha-tocopheryl acetate nor alpha-tocopheryl succinate prevented photocarcinogenesis. At 12.5 and 25 mg/treatment, alpha-tocopheryl acetate and alpha-tocopheryl succinate, respectively, enhanced photocarcinogenesis (p = 0.0114 and 0.0262, respectively, log rank test). On the basis of high-performance liquid chromatography analysis at 16-17 weeks after the first vitamin E treatment, the esterified forms of vitamin E applied epicutaneously accumulated in the skin, but the levels of free alpha-tocopherol remained low. Neither alpha-tocopheryl acetate nor alpha-tocopheryl succinate prevented the induction by UV radiation of immunosusceptibility to implanted syngeneic antigenic UV-induced tumor cells. Thus alpha-tocopheryl acetate or alpha-tocopheryl succinate not only failed to prevent photocarcinogenesis, but may have enhanced to process. Considering that alpha-tocopherol esters are included in many skin lotions, cosmetics, and sunscreens, further studies are needed to determine the conditions under which topical alpha-tocopheryl acetate and alpha-tocopheryl succinate enhance photocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875555     DOI: 10.1080/01635589609514474

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  6 in total

Review 1.  The Tricky Tear Trough: A Review of Topical Cosmeceuticals for Periorbital Skin Rejuvenation.

Authors:  Stacey J Pilkington; Sarah Belden; Richard A Miller
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

Review 2.  [Sebaceous glands as transporters of vitamin E].

Authors:  S Ekanayake-Mudiyanselage; J Thiele
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

3.  Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Authors:  Janet A Foote; James R Ranger-Moore; Janine G Einspahr; Kathylynn Saboda; Jaime Kenyon; James Warneke; Richard C Miller; Rayna Goldman; Min-Jian Xu; Denise J Roe; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31

Review 4.  The role of phytonutrients in skin health.

Authors:  Julie A Evans; Elizabeth J Johnson
Journal:  Nutrients       Date:  2010-08-24       Impact factor: 5.717

5.  Differential effects of topical vitamin E and C E Ferulic® treatments on ultraviolet light B-induced cutaneous tumor development in Skh-1 mice.

Authors:  Erin M Burns; Kathleen L Tober; Judith A Riggenbach; Donna F Kusewitt; Gregory S Young; Tatiana M Oberyszyn
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

6.  A novel skin brightening topical technology.

Authors:  Zoe Diana Draelos; Isabel Diaz; Aaron Cohen; Junhong Mao; Thomas Boyd
Journal:  J Cosmet Dermatol       Date:  2020-10-12       Impact factor: 2.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.